GLP-1 Providers in Maryland (2026)

185 sellers list Maryland as a shipping state. The lowest regular price among them is $79/mo, and Maryland Medicaid does not cover weight loss.

185 sellersfrom $79/moMedicaid does not cover weight loss

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

185 of the 238 sellers that publish a state list include Maryland, the 11th-most of the 50 states and DC. 128 of them ship to all 50 states, and 5 serve 15 states or fewer. Across the 153 with a regular monthly price, the middle figure is $179/mo.

Maryland Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Featured Partners · Maryland

Featured GLP-1 providers serving Maryland

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

  1. Top pick

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →
  5. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. Compounded from

    $112/mo

    Save $1,237/mo vs Wegovy
    Get started →

Who Ships GLP-1s to Maryland

  1. Embody $79/mo
  2. Lean Meds $79/mo
  3. NextMeds $79/mo

Lowest regular prices for Maryland: Embody at $79/mo, Lean Meds at $79/mo and NextMeds at $79/mo.

Smaller-footprint sellers that include Maryland: TD Tele-Doc Weight Loss (2 states), Rivas Medical Weight Loss (3 states), Enara Health (6 states), OlleveCare (13 states) and The Aesthetic Concierge (13 states).

2 sellers that list 30 or more states leave Maryland off, among them Brello Health and Care Clinics.

Seller counts next door: District of Columbia 37, Delaware 176, Pennsylvania 186, Virginia 190 and West Virginia 167.

Browse by medication

Maryland Medicaid and GLP-1 Coverage

Maryland Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

  • Wegovy to cut heart attack and stroke risk: covered with prior authorization (a BMI of at least 27; Age 18+, a cardiologist consult, BMI of at least 27 recorded within 90 days, no type 1 diabetes/type 2 diabetes, and established atherosclerotic cardiovascular disease, symptomatic peripheral artery disease, a prior ischemic or hemorrhagic stroke, or a prior heart attack. Billing goes per invoice through the HCPCS J3490 medical benefit, not retail pharmacy).
  • Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2/F3).
  • Zepbound for obstructive sleep apnea: not covered.
Prior authorization
Prior authorization formMDH Wegovy Preauthorization Criteria (last reviewed 11/30/2025)
Prior authorization phone833-325-0105
Urgent decisionwithin 72 hours
Pharmacy benefit managerConduent (FFS pharmacy) / Acentra Health (MMPP); MCO-level Prime Therapeutics among others
Enrollmentabout 1,600,000 people (2026)
If the request is denied
Time to file an appeal90 days
Appeals officeMaryland Office of Administrative Hearings (OAH)
Rule that governs itCOMAR 10.67.09.05
Fast-track appealavailable when waiting would put your health at risk
“In accordance with COMAR 10.09.03.05 (A)(14), prescriptions for weight control indications will not be covered at this time.”
MDH Pharmacy News & Views, November 2025, anchored at COMAR 10.09.03.05(A)(14)

In 2025, Maryland Medicaid paid for at least 148,487 GLP-1 prescriptions, including at least 101,266 for Ozempic, at least 1,140 for Wegovy, at least 18,446 for Mounjaro and at least 1,909 for Zepbound, about $142.7 million before manufacturer rebates. Drugs labeled for weight loss made up 2% of that spending.

Medicaid rules checked May 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Maryland

Maryland has 1,137 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 18.15 per 100,000 residents (1st of 51). By specialty: 530 bariatric, 605 endocrinology and 16 obesity medicine. About 32.7% of adults here had obesity in 2024 (CDC), the 31st-highest rate of the 50 states and DC. Measured against the median state, Maryland has 0.45 times as much adult obesity per specialist practice.

Every GLP-1 Provider Serving Maryland

9.3/ 10
Verified partner

Embody

Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy

★★★★★4.7/5

Editorial score · methodology

$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →
9.0/ 10
Verified partner

Live Vital

Best for: semaglutide at $99/month, 48% below the typical price

★★★★★4.5/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideRetatrutideBPC-157
Get StartedRead full Live Vital review →
8.7/ 10
Verified partner

Gala

Best for: moving between compounded and brand without changing seller

★★★★☆4.4/5

Editorial score · methodology

$129/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Gala review →
8.6/ 10
Verified partner

Found

Best for: tirzepatide at $169/month, 37% below the typical price

★★★★☆4.3/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →
7.3/ 10
Verified partner

Willow

Best for: seeing what it charges before you answer any medical questions

★★★★☆3.7/5

Editorial score · methodology

$299/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Willow review →
Open the full A–Z list of 185 providers in Maryland

312 more sellers publish no state list

Their signup form tells you whether they ship to Maryland.

5.7/ 10
Verified partner

HumeCare+

Best for: an oral route if you will not self-inject

★★★☆☆2.9/5

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full HumeCare+ review →
6.5/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★☆☆3.3/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
8.4/ 10
Verified partner

Collective

Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top

★★★★☆4.2/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
7.7/ 10
Verified partner

HealthRX

Best for: compounded semaglutide at $133/month

★★★★☆3.9/5

Editorial score · methodology

$133/mo
SemaglutideTirzepatide
Get StartedRead full HealthRX review →
7.3/ 10
Verified partner

RNK Health

Best for: an oral route if you will not self-inject

★★★★☆3.7/5

Editorial score · methodology

$197/mo
CompoundedSemaglutideTirzepatideNAD+Sermorelin
Get StartedRead full RNK Health review →
5.9/ 10
Verified partner

SkinnyRx

Best for: starting below a standard dose, with microdose tiers

★★★☆☆3/5

Editorial score · methodology

$149.25/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full SkinnyRx review →

Largest Cities in Maryland

BaltimoreFrederickRockvilleGaithersburg

Frequently Asked Questions

The lowest regular prices from sellers that ship to Maryland are $79/mo at Embody, $79/mo at Lean Meds and $79/mo at NextMeds. Half of the 153 priced sellers charge $179/mo or less.
Maryland Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization. Wegovy to cut heart attack and stroke risk: covered with prior authorization (a BMI of at least 27; Age 18+, a cardiologist consult, BMI of at least 27 recorded within 90 days, no type 1 diabetes/type 2 diabetes, and established atherosclerotic cardiovascular disease, symptomatic peripheral artery disease, a prior ischemic or hemorrhagic stroke, or a prior heart attack. Billing goes per invoice through the HCPCS J3490 medical benefit, not retail pharmacy). Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2/F3). Zepbound for obstructive sleep apnea: not covered.
Your prescriber sends the request on this paperwork: MDH Wegovy Preauthorization Criteria (last reviewed 11/30/2025). Pharmacy claims run through Conduent (FFS pharmacy) / Acentra Health (MMPP); MCO-level Prime Therapeutics among others. The prior authorization phone line is 833-325-0105.
A denial can be appealed within 90 days through the Maryland Office of Administrative Hearings (OAH). A fast-track appeal is available when waiting would put your health at risk.
185, counting sellers whose published state list includes Maryland. 128 of those list every state, and TD Tele-Doc Weight Loss, Rivas Medical Weight Loss and Enara Health are among the few that serve 15 states or fewer. For comparison, District of Columbia has 37, Delaware has 176 and Pennsylvania has 186.
Brello Health (35 states) and Care Clinics (32 states) publish long state lists that leave Maryland out.
In 2025, Maryland Medicaid paid for at least 148,487 GLP-1 prescriptions, including at least 101,266 for Ozempic, at least 1,140 for Wegovy, at least 18,446 for Mounjaro and at least 1,909 for Zepbound, about $142.7 million before manufacturer rebates. Drugs labeled for weight loss made up 2% of that spending.
Maryland has 1,137 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 18.15 per 100,000 residents (1st of 51). By specialty: 530 bariatric, 605 endocrinology and 16 obesity medicine. About 32.7% of adults here had obesity in 2024 (CDC), the 31st-highest rate of the 50 states and DC. Measured against the median state, Maryland has 0.45 times as much adult obesity per specialist practice.

Rankings: semaglutide providers · tirzepatide providers · clinical-trial results · GLP-1 pipeline

Glossary

The words sellers use, defined. Tap any term.